NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-for ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Savara (SVRA) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar E ...

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submission ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212- 983-9330Â (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 23, ...

Accessibility StatementSkip Navigation WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statemen ...

集体诉讼案件背景 - Rosen Law Firm提醒在2024年3月7日至2025年5月23日期间购买Savara Inc (NASDAQ: SVRA) 证券的购买者注意2025年11月7日的重要首席原告截止日期 [1] - 在此特定期间购买Savara证券的投资者可能有权通过风险代理收费安排获得补偿，无需支付任何自付费用 [1] 诉讼案件核心指控 - 指控称被告作出了虚假和/或误导性陈述，未能披露其针对罕见肺病治疗的MOLBREEVI临床试验生物制剂许可证申请缺乏有关化学、制造和控制的足够信息 [4] - 因此美国FDA不太可能以当前形式批准MOLBREEVI的BLA申请 [4] - 上述情况使得Savara不太可能在其向投资者承诺的时间框架内完成MOLBREEVI的BLA提交 [4] - MOLBREEVI监管批准的延迟增加了Savara需要筹集额外资金的可能性 [4] - 据称当真实细节进入市场后，投资者遭受了损失 [4] 律所资质与背景 - Rosen Law Firm专注于证券集体诉讼和股东衍生诉讼，在全球代表投资者 [3] - 该律所曾达成针对中国公司的史上最大证券集体诉讼和解案，并在2017年被ISS Securities Class Action Services评为证券集体诉讼和解数量第一名 [3] - 自2013年以来，该律所每年均排名前四，为投资者追回数亿美元，仅在2019年就为投资者确保了超过4.38亿美元 [3]

Accessibility StatementSkip Navigation NEW YORK, Oct. 21, 2025 /PRNewswire/ --Â Levi &Â Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: SOURCE Levi & Ko ...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submission ...

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of SVRA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is November 7, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the ...

诉讼事件概述 - 一家全国知名的股东权益律师事务所Bragar Eagel & Squire, P C宣布，已代表在2024年3月7日至2025年5月23日期间购买或收购Savara Inc证券的所有个人和实体，向美国宾夕法尼亚州东区地方法院提起集体诉讼 [8] - 投资者申请成为诉讼首席原告的截止日期为2025年11月7日 [8] 指控核心内容 - 指控称，被告在集体诉讼期间未能披露以下信息：Molbreevi生物制剂许可申请缺乏关于其化学、制造和控制的足够信息 [8] - 指控称，被告未能披露因此美国FDA不太可能以当前形式批准Molbreevi的BLA [8] - 指控称，被告未能披露上述情况使得Savara不太可能在其向投资者承诺的时间框架内完成Molbreevi BLA的提交 [8] - 指控称，被告未能披露Molbreevi监管批准的延迟增加了公司需要筹集额外资金的可能性 [8] 股价影响事件 - 2025年5月27日，Savara发布新闻稿，宣布公司收到FDA针对Molbreevi BLA的拒绝提交信函，FDA在初步审查后确定该申请不够完整，无法进行实质性审查，并要求提供更多与化学、制造和控制相关的数据 [8] - 受此消息影响，Savara股价每股下跌0.90美元，跌幅达31.69%，于2025年5月27日收于每股1.94美元 [8]